{
    "Trade/Device Name(s)": [
        "Olympus IgM reagent (OSR6X173)",
        "IgM reagent"
    ],
    "Submitter Information": "Olympus America Inc.",
    "510(k) Number": "K073487",
    "Predicate Device Reference 510(k) Number(s)": [
        "K950900"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CFN"
    ],
    "Summary Letter Date": "February 11, 2008",
    "Summary Letter Received Date": "December 12, 2007",
    "Submission Date": "December 11, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A, G, M, D, E immunological test systems"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "IgM"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (Li-heparin and EDTA)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Olympus AU400/400",
        "Olympus AU600/640/640\u00ae",
        "Olympus AU2700/5400"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetric"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Olympus IgM reagent (OSR6X173), an immunoturbidimetric assay for quantitative IgM measurement on Olympus analyzers.",
    "Indications for Use Summary": "System reagent for the quantitative determination of IgM immunoglobulins in human serum and plasma on OLYMPUS analyzers; aids in diagnosing abnormal protein metabolism and immune deficiencies.",
    "fda_folder": "Immunology"
}